Valleylab™ FX8 Energy Platform

Product Details

Electrosurgery with the power of precision

Our new Valleylab™ FX8 energy platform puts the power of precision in your hands.([FOOTNOTE=Based on internal test report #RE00005401, Product validation of Valleylab™ FT10 energy platform surgeon and nurse evaluation in simulated use: 32 surgeons interviewed. January 27 to 30, 2015 and Feb. 24 to 27, 2015.],[ANCHOR=],[LINK=]),([FOOTNOTE=Based on internal report #RE00105221, Comparison testing of the Valleylab™ FT10 and ForceTriad™ generators. The Valleylab™ FT10 energy platform has identical power curves and equivalent power delivery for shared modes to the Valleylab™ FX8 energy platform. July 2017.],[ANCHOR=],[LINK=]),† Now, your electrosurgical handpieces can adapt to variable tissue — in real time.([FOOTNOTE=Based on internal report # RE00077924, Marketing evaluation of the Valleylab™ FX8 energy platform: nurse and surgeon report. June 2017.],[ANCHOR=],[LINK=]),†

Valleylab™ FT10 Energy Platform

Product Details

Valleylab™ FT10 energy platform is our next generation advanced energy platform with improved LigaSure™ vessel sealing technology and expanded electrosurgical features.

Valleylab™ LS10 Generator

Product Details

The new Valleylab™ LS10 electrosurgical generator provides you with the essential energy that you need. Both affordable and portable, the LS10 generator makes the next generation of LigaSure™ vessel sealing technology accessible to customers around the globe. The platform is intended for open and laparoscopic surgical procedures and includes:

  • TissueFect™ sensing technology across all modalities
  • LigaSure™ fusion technology for vessel sealing

*The Valleylab™ LS10 generator is not available for sale in the United States.

Force EZ™ Electrosurgical Generator C with Instant Response™ Technology

Product Details

The Force EZ™ generator C with Instant Response™ technology is designed for most monopolar and bipolar procedures, with a PER of 97 in cut. It adjusts automatically, responding to tissue changes, maintaining power delivery, and minimizing drag. This offers a smoother cut through all tissue types.

Instant Response™ technology provides surgeons with improved performance at lower power settings, minimizing the risk of tissue damage and neuromuscular stimulation, and decreasing the need to “turn up the generator.” Lower voltage means less neuromuscular stimulation and more precise delivery of energy to reduce collateral damage.

Order Information

Order Information
Order Code Description Unit of Measure Quantity
FORCEEZC Force EZ™ Electrosurgical Generator C with Instant Response™ Technology 110-120V Each 1
FORCE EZ-8C Force EZ™ Electrosurgical Generator C with Instant Response™ Technology 220-240V Each 1

Valleylab™ Bipolar Current Monitor

Product Details

The Valleylab™ bipolar current monitor provides a relative indication of tissue desiccation during bipolar electrosurgery. The monitor indicates the current being delivered to the surgical site.

Visual and audible indicators offer real-time feedback of current flow at the surgical site. Current level can be easily read at a glance. The adjustable audible tone reinforces the visual display.

Convenient design allows the unit to be positioned within clear view of the surgical staff using a 20 foot cord.

Order Information

Order Information
Order Code Description Unit of Measure Quantity
VLCM Valleylab™ Bipolar Current Monitor Each 1


Safety and performance

All Medtronic electrosurgical generators offer safety and performance features, including isolated output, independent activation of accessories, and the patented Valleylab REM™ contact quality monitoring system, which substantially reduces the risk of burns under the patient return electrode. The Valleylab REM™ system, the first of its kind, has been proven in more than 100 million surgical procedures worldwide.

Product Training & Support

Access in-service training videos, product guides, frequently asked questions, and other product support for your electrosurgical hardware.

  • †20 out of 20 surgeons surveyed agreed.